Article Versions Notes

Resende H, Aguiar VdQ, Santos NFdA, Jardim JVS, Ornelas A. Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil. Current Oncology. 2025; 32(8):471. https://doi.org/10.3390/curroncol32080471

Resende, Heloisa, Vinícius de Q. Aguiar, Nataline F. de A. Santos, João Vitor Siqueira Jardim, and André Ornelas. 2025. "Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil" Current Oncology 32, no. 8: 471. https://doi.org/10.3390/curroncol32080471

Resende, H., Aguiar, V. d. Q., Santos, N. F. d. A., Jardim, J. V. S., & Ornelas, A. (2025). Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil. Current Oncology, 32(8), 471. https://doi.org/10.3390/curroncol32080471